EKF Diagnostics (LON:EKF) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

EKF Diagnostics Holdings plc (LON:EKF)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 25.58 and traded as low as GBX 25.20. EKF Diagnostics shares last traded at GBX 25.50, with a volume of 423,143 shares.

Wall Street Analysts Forecast Growth

Separately, Stifel Nicolaus reissued a “buy” rating and set a GBX 35 price target on shares of EKF Diagnostics in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of GBX 35.

EKF Diagnostics Stock Performance

The company has a debt-to-equity ratio of 2.01, a current ratio of 4.16 and a quick ratio of 1.77. The company has a market capitalization of £111.79 million, a PE ratio of 55.32 and a beta of 0.51. The firm’s fifty day simple moving average is GBX 25.85 and its 200 day simple moving average is GBX 25.56.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.